Kwality Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹181 crore and net profit of ₹29 crore for the September 2026 quarter.
Kwality Pharma (NSE: KPL) closed at ₹4,128.40 on 20 Nov 2026. Its market capitalisation is ₹4,284 crore and it trades at 44.4 times earnings.
Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.